Skip to content

Fortive

US · FTV #1059 by market cap Listed 2016
64.16 -1.25 -1.91%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions decreased by 2 in the most recent period (2026/Q4).
  • Total institutional ownership rose 0.2 percentage points.

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
109.81% +0.24pp
Institutions
945 -2
As of
2026/Q4 vs. prior period

Holder types

Mutual Fund88.66%
Hedge Fund11.49%
Public Company2.71%
Sovereign Wealth Fund2.52%
Government Pension Fund2.11%
Private Company1.45%
Insurance Company0.30%
Individual/Insider0.27%
Family Office/Trust0.18%

Top holders as of 2026-09-30

Dodge & Cox 14.21% · 42.30M sh
BlackRock 9.23% · 27.48M sh
T. Rowe Price Group, Inc. 8.19% · 24.39M sh
Vanguard Capital Management, LLC 7.22% · 21.49M sh
Viking Global Investors LP 6.66% · 19.82M sh
State Street Global Advisors 4.58% · 13.62M sh
Vanguard Portfolio Management, LLC 4.13% · 12.29M sh
Flossbach von Storch SE 3.95% · 11.77M sh
Geode Capital Management, LLC 3.10% · 9.21M sh
Barrow, Hanley, Mewhinney & Strauss, LLC 2.98% · 8.87M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 37 buys · 13 sells

NameRoleStake
Olumide Soroye Chief Executive Officer 0.09%
James Lico Former Advisor 0.05%
Peter Underwood Chief Legal Officer 0.03%
Jonathan Schwarz Former Officer 0.03%
Christopher Mulhall Chief Accounting Officer 0.02%
Edward Simmons Former Senior Vice President of Strategy 0.02%
Daniel Comas Independent Director 0.01%
Tamara Newcombe Former President and CEO of Precision Technologies & Advanced Healthcare Solutions 0.01%
Mark Okerstrom Senior Vice President 0.01%
Charles McLaughlin Former Officer 0.00%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-10-29 Peter Underwood Chief Legal Officer Derivative Exercise and Sale -48,442 $34.85–64.60
2026-10-29 Christopher Mulhall Chief Accounting Officer Open Market Disposition -7,624 $65.56–65.57
2026-10-29 Christopher Mulhall Chief Accounting Officer Derivative Exercise and Sale -18,431 $34.85–65.57
2026-09-24 Wright Lassiter Independent Director Other Acquisition +5 $55.92
2026-09-24 Peter Underwood Chief Legal Officer Other Derivative Acquisition +17 --
2026-09-24 Mark Okerstrom Senior Vice President Other Derivative Acquisition +4 --
2026-09-24 Olumide Soroye Chief Executive Officer Other Derivative Acquisition +14 --
2026-09-24 Amee Desjourdy Chief Human Resources Officer Other Derivative Acquisition +1 --
2026-09-24 Christopher Mulhall Chief Accounting Officer Other Derivative Acquisition +10 --
2026-08-09 Peter Underwood Chief Legal Officer Open Market Disposition -8,662 $61.59
2026-07-23 Mark Okerstrom Senior Vice President Other Derivative Acquisition +188 --
2026-07-05 Peter Underwood Chief Legal Officer Other Derivative Acquisition +13 --
2026-07-05 Mark Okerstrom Senior Vice President Other Derivative Acquisition +3 --
2026-07-05 Olumide Soroye Chief Executive Officer Other Derivative Acquisition +11 --
2026-07-05 Amee Desjourdy Chief Human Resources Officer Other Derivative Acquisition +1 --
2026-07-05 Christopher Mulhall Chief Accounting Officer Other Derivative Acquisition +7 --
2026-07-01 Wright Lassiter Independent Director Other Acquisition +4 $62.12
2026-07-01 Olumide Soroye Chief Executive Officer Sale to Issuer -3,777 $62.65
2026-06-17 Eric Branderiz Former Independent Director Intent to Sell (Form 144) -15,897 $61.76
2026-06-08 Kate Mitchell Independent Director Other Acquisition +3,350 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 20:02:43 · For reference only, not investment advice and not tailored to your situation.

Fortive discussion 0 comments

Add a comment